Kohort studies;Kohortenstudien

Wiener Medizinische Wochenschrift

Volumn 158, Issue 5-6, 2008, Pages 174-179

  Mathis, Stefan ^a   Gartlehner, Gerald ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Cohort; Cohort study; Confounding; Evidence based medicine; Exposition; Follow up study; Health technology assessment; Longitudinal study; Observational study; Outcome; Selection bias

Indexed keywords

COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL ASSESSMENT; MEDICAL RESEARCH; REVIEW; VALIDITY;

BIOMEDICAL TECHNOLOGY; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SELECTION BIAS;

EID: 42049092096     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-008-0516-0     Document Type: Review

References (17)

1. Kunz R, Lühmann D, Windeler J, Lelgemann M, Donner-Banzhoff N (2006) Glossar zur Evidenzbasierten Medizin. http://www.ebm-netzwerk.de/grundlagen/ grundlagen/images/glossar_060920.pdf
2. Higgins J, Green S (2006) Cochrane Handbook for Systematic Reviews of Interventions 4.2.6.
3. Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312(7040): 1215-1218
4. Grimes DA, Schulz KF (2002) Bias and causal associations in observational research. Lancet 359(9302): 248-252
5. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7(27): iii-x, 1-173
6. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335(7): 453-461
7. Vandenbroucke JP (2004) When are observational studies as credible as randomised trials? Lancet 363(9422): 1728-1731
8. Grimes DA, Schulz KF (2002) Cohort studies: marching towards outcomes. Lancet 359(9303): 341-345
9. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, Goltzman D, for the Canadian Multicentre Osteoporosis Study Research G (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167(2): 188-194
10. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM (2005) Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. Bmj 330(7497): 960-962
11. Müllner M (2005) Erfolgreich wissenschaftlich arbeiten in der Klinik: Evidence based medicine. 2., Überarb. und erw. Aufl. Springer, Wien
12. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349(6): 523-534
13. Million Women Study Collaborators (2002) Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. Bjog 109(12): 1319-1330
14. Agency for Healthcare Research and Quality (2007) Effective Health Care Home. http://effectivehealthcare.ahrq.gov/
15. OHSU Oregon Health & Science University (2007) Drug Effectiveness Review Project. http://www.ohsu.edu/drug-effectiveness/
16. Rochon PA, Gurwitz JH, Sykora K, Mamdani M, Streiner DL, Garfinkel S, Normand SL, Anderson GM (2005) Reader's guide to critical appraisal of cohort studies: 1. Role and design. Bmj 330(7496): 895-897
17. Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM (2005) Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. Bmj 330(7498): 1021-1023